ES2066206T3 - Utilizacion de adenilciclasa como vacunas contra bordetella. - Google Patents

Utilizacion de adenilciclasa como vacunas contra bordetella.

Info

Publication number
ES2066206T3
ES2066206T3 ES90908234T ES90908234T ES2066206T3 ES 2066206 T3 ES2066206 T3 ES 2066206T3 ES 90908234 T ES90908234 T ES 90908234T ES 90908234 T ES90908234 T ES 90908234T ES 2066206 T3 ES2066206 T3 ES 2066206T3
Authority
ES
Spain
Prior art keywords
vaccines against
adenyl cyclase
against bordetella
preparation
prepared
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90908234T
Other languages
English (en)
Inventor
Nicole Guiso-Maclouf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur de Lille
Original Assignee
Institut Pasteur de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur de Lille filed Critical Institut Pasteur de Lille
Application granted granted Critical
Publication of ES2066206T3 publication Critical patent/ES2066206T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SEGUN LA INVENCION, SE UTILIZA UNA PREPARACION DE VACUNA BACTERIANA ELABORADA A PARTIR DE UNA DETERMINADA BACTERIA DEL GENERO BORDETELLA O DE UNA ADENILA CICLASA PARA PREPARAR UN ANTIGENO PROTECTOR PARA EL HOMBRE O EL ANIMAL CONTRA LAS INFECCIONES Y LOS EFECTOS TOXICOS CAUSADOS POR UNA BACTERIA DEL GENERO BORTEDELLA PERO DIFERENTE DE LA PREPARACION DE LA VACUNA.
ES90908234T 1989-05-12 1990-05-11 Utilizacion de adenilciclasa como vacunas contra bordetella. Expired - Lifetime ES2066206T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8906321A FR2646776B1 (fr) 1989-05-12 1989-05-12 Utilisation de preparations vaccinantes a base d'adenyl cyclase ou de bacteries les produisant en tant qu'antigenes protecteurs contre les effets des bordetella

Publications (1)

Publication Number Publication Date
ES2066206T3 true ES2066206T3 (es) 1995-03-01

Family

ID=9381646

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90908234T Expired - Lifetime ES2066206T3 (es) 1989-05-12 1990-05-11 Utilizacion de adenilciclasa como vacunas contra bordetella.

Country Status (10)

Country Link
US (3) US6214356B1 (es)
EP (1) EP0424518B1 (es)
JP (1) JP3399525B2 (es)
AT (1) ATE115861T1 (es)
CA (1) CA2033085C (es)
DE (1) DE69015314T2 (es)
ES (1) ES2066206T3 (es)
FR (1) FR2646776B1 (es)
PT (1) PT94030B (es)
WO (1) WO1990013312A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2646776B1 (fr) 1989-05-12 1994-06-03 Pasteur Institut Utilisation de preparations vaccinantes a base d'adenyl cyclase ou de bacteries les produisant en tant qu'antigenes protecteurs contre les effets des bordetella
FR2728170A1 (fr) 1994-12-15 1996-06-21 Pasteur Institut Vaccin de type acellulaire anti-bordetella
US6030625A (en) * 1994-12-15 2000-02-29 Institut Pasteur Bordetella pertussis and Bordetella parapertussis strains
FR2736064B1 (fr) 1995-06-30 1997-09-05 Pasteur Institut Epitopes protecteurs de l'adenyl cyclase-hemolysine(ac-hty). leur application au traitement ou a la prevention des infections par bordetella
US7462472B2 (en) * 2001-11-02 2008-12-09 The University Of Chicago Methods and compositions relating to anthrax pathogenesis
WO2005032584A2 (en) 2003-10-02 2005-04-14 Glaxosmithkline Biologicals S.A. Pertussis antigens and use thereof in vaccination
US7521059B2 (en) * 2004-06-14 2009-04-21 Fenwick Bradley W Kennel cough vaccine

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8412207D0 (en) * 1984-05-12 1984-06-20 Wellcome Found Antigenic preparations
US5237052A (en) 1984-05-12 1993-08-17 Burroughs Wellcome Company Antigenic preparations and isolation of such preparations
US4652521A (en) * 1985-03-04 1987-03-24 Regents Of The University Of Minnesota Method for the early diagnosis of bordetella diseases and kit therefor
FR2590483B1 (fr) * 1985-11-22 1988-12-09 Pasteur Institut Antigenes purifies ayant des proprietes vaccinantes contre b. pertussis, moyens notamment adns recombinants pour les produire et compositions de vaccins les contenant
EP0267998A1 (en) * 1986-11-17 1988-05-25 Institut Pasteur Means for protecting against bordetella infections and toxic processes
FR2606789B1 (fr) * 1986-11-17 1991-05-31 Pasteur Institut Preparations d'adenylate cyclase purifiees, procede d'obtention de ces preparations et leurs applications biologiques
FR2621597B1 (fr) 1987-07-24 1992-07-31 Pasteur Institut Procede de clonage et d'expression de genes codant pour des proteines constituant des edifices fonctionnels organises
DE3855442T2 (de) * 1988-04-19 1997-03-06 Inst Nat Sante Rech Med Verfahren zur Gewinnung von Schutzantigenen gegen Bordetella-Infektionen und toxische Prozesse
EP0338170A1 (en) * 1988-04-19 1989-10-25 Institut Pasteur Immunoprotective antigenic protein against pathogenic bacteria
FR2638169B1 (fr) * 1988-10-25 1991-01-11 Pasteur Institut Derives d'adenyl cyclase et leurs utilisations biologiques
FR2646776B1 (fr) 1989-05-12 1994-06-03 Pasteur Institut Utilisation de preparations vaccinantes a base d'adenyl cyclase ou de bacteries les produisant en tant qu'antigenes protecteurs contre les effets des bordetella
DE69018926T2 (de) * 1989-09-04 1995-08-24 Wellcome Found Vakzine gegen Bordetella.
US5786189A (en) * 1989-11-29 1998-07-28 Smithkline Beecham Biologicals (S.A.) Vaccine
HU219819B (hu) * 1992-08-18 2001-08-28 Dimminaco Ag/Sa/Ltd. Izolált polinukleotidok, ezeket tartalmazó Bordetella bronchiseptica törzs, és Bordetella bronchiseptica elleni vakcina
US6030625A (en) * 1994-12-15 2000-02-29 Institut Pasteur Bordetella pertussis and Bordetella parapertussis strains
FR2728170A1 (fr) * 1994-12-15 1996-06-21 Pasteur Institut Vaccin de type acellulaire anti-bordetella
EP1234580A1 (en) * 1995-05-04 2002-08-28 Aventis Pasteur Limited Acellular Pertussis Vaccines and Methods of Preparation Thereof
FR2736064B1 (fr) * 1995-06-30 1997-09-05 Pasteur Institut Epitopes protecteurs de l'adenyl cyclase-hemolysine(ac-hty). leur application au traitement ou a la prevention des infections par bordetella
GB9718901D0 (en) * 1997-09-05 1997-11-12 Smithkline Beecham Biolog Vaccine
JP2003533990A (ja) * 2000-05-25 2003-11-18 インスティチュート・パスツール 百日咳菌、パラ百日咳菌および気管支敗血症菌のペルタクチンの繰返し領域の多型性を有するポリペプチド、ならびに診断および免疫原性組成物におけるその使用
PT1188446E (pt) 2000-09-15 2009-11-10 Pasteur Institut Vectores proteinácios para a distribuição da molécula a células que expressam cd11b

Also Published As

Publication number Publication date
PT94030A (pt) 1991-01-08
CA2033085A1 (fr) 1990-11-13
DE69015314D1 (de) 1995-02-02
US6214356B1 (en) 2001-04-10
EP0424518B1 (fr) 1994-12-21
JP3399525B2 (ja) 2003-04-21
EP0424518A1 (fr) 1991-05-02
CA2033085C (fr) 2003-07-22
US7211263B2 (en) 2007-05-01
ATE115861T1 (de) 1995-01-15
US20020172691A1 (en) 2002-11-21
WO1990013312A1 (fr) 1990-11-15
FR2646776B1 (fr) 1994-06-03
US20030224003A1 (en) 2003-12-04
DE69015314T2 (de) 1996-11-28
PT94030B (pt) 1997-07-31
FR2646776A1 (fr) 1990-11-16
JPH03506044A (ja) 1991-12-26

Similar Documents

Publication Publication Date Title
NO20015073D0 (no) Vaksiner
PT777490E (pt) Enterotoxina mutante eficaz como adjuvante oral nao toxico
ES2176232T3 (es) Vacuna adecuada para ser utilizada en la prevencion y tratamiento de la infeccion por helicobacter.
ES2192582T3 (es) Composicion de vaccineo, conteniendo quitina, parcialmente deacetilado.
ES2075325T3 (es) Subunidad de vacuna contra el actinobacillus pleuropneumoniae.
ATE556596T1 (de) Regulierte attenuierung von lebendimpfstoffen zur verbesserung der kreuzimmunitätsschutzfunktion
MX9301706A (es) Composicion de vacuna para el tratamiento de la infeccion por helicobacter.
ES2150419T3 (es) Procedimiento de atenuacion bacteriana y vacuna.
PT672116E (pt) Mutantes por supressao como vacinas contra a colera
ES2158108T3 (es) Vacunacion in ovo contra la coccidiosis.
ES2070266T3 (es) Vacuna contra la infeccion por escherichia coli.
AR052855A1 (es) Composiciones para el cuidado bucal que contienen un extrato de eucalyptus
AR010583A1 (es) CULTIVO DE CÉLULAS DE UNA CEPA DERIVADA DE UNA CEPA PROGENITORA DE UNA ESPECIE DE NEOSPORA, VACUNA QUE LAS CONTIENE, Y COMPOSICIoN.
MX2020008454A (es) Composicion inmunogenica que comprende antigenos estafilococicos.
AR023535A1 (es) Nuevas composiciones.
PT1024824E (pt) Composicao de vacina dispersivel solida para administracao oral
HUP0301634A2 (hu) Hőmérséklet-érzékeny, élő vakcina Mycoplasma hyopneumoniaera
ES2066206T3 (es) Utilizacion de adenilciclasa como vacunas contra bordetella.
ATE458496T1 (de) Hiv-vakzine und anwendungsverfahren
AR039982A1 (es) Composicion vacunal contra las alergias, metodo para su obtencion y empleo en el tratamiento de las mismas
AR044339A1 (es) Composicion de vacuna aviar para la proteccion de aves de corral contra enfermedades e infeccion causadas por e. coli y salmonella
AR009650A1 (es) Mycoplasma synoviae atenuado vivo, su uso, un cultivo microbiologico que lo comprende, una vacuna bacteriana atenuada viva para la proteccion de las aves de corral contra la infeccion por mycoplasma synoviae y un metodo para preparar dicha vacuna.
HUP9700975A2 (hu) Élő, legyengített, Pasteurellaceae családba tartozó, RTX-termelő baktériumok
AR023536A1 (es) Vacunas
BR0007966A (pt) Composições e métodos para o tratamento e a prevenção de infecção bacteriana patogênica com base na função essencial da metilação do dna na virulência bacteriana

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 424518

Country of ref document: ES